Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
Overall BMY gets a fundamental rating of 6 out of 10. We evaluated BMY against 198 industry peers in the Pharmaceuticals industry. BMY has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on BMY. Finally BMY also has an excellent dividend rating. With these ratings, BMY could be worth investigating further for value and dividend investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.86% | ||
ROE | 31.16% | ||
ROIC | 14.88% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.11% | ||
PM (TTM) | 11.38% | ||
GM | 74.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 2.67 | ||
Debt/FCF | 3.8 | ||
Altman-Z | 2.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.28 | ||
Quick Ratio | 1.17 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 6.24 | ||
Fwd PE | 7.43 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 7.12 | ||
EV/EBITDA | 6.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.29% |